NDA 091612 describes TENOFOVIR DISOPROXIL FUMARATE, which is a drug marketed by
Aurobindo Pharma,
Chartwell,
Chartwell Rx,
Cipla,
Hetero Labs Ltd Iii,
Macleods Pharms Ltd,
Norvium Bioscience,
Qilu,
Reyoung,
Strides Pharma, and
Teva Pharms Usa, and is included in twelve NDAs. It is available from
fifteen suppliers. Additional details are available on the
TENOFOVIR DISOPROXIL FUMARATE profile page.
The generic ingredient in TENOFOVIR DISOPROXIL FUMARATE is
tenofovir disoproxil fumarate. There are forty-two
drug master file entries for this compound. Sixteen
suppliers are listed for this compound. Additional details are available on the
tenofovir disoproxil fumarate profile page.